You have 9 free searches left this month | for more free features.

Schizophrenic patients according to DSM-IV

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Periodontitis in Schizophrenic Patients

Completed
  • Schizophrenia Spectrum and Other Psychotic Disorders
  • Periodontal Diseases
  • antipsychotic drugs inducing hyperprolactinemia
  • Giza, Egypt
    Rania Hassan Shalby
Sep 10, 2023

Insomnia, Schizophrenia Trial in Barcelona (cognitive behavioural intervention)

Completed
  • Insomnia
  • Schizophrenia
  • cognitive behavioural intervention
  • Barcelona, Catalonia, Spain
    Nou Barris Mental Health Center
Sep 27, 2022

Chronic Non-Cancer Pain: Risks and Benefits

Enrolling by invitation
  • Chronic Non-Cancer Pain
  • Opioid Use Disorder
    • Uppsala, Sweden
      Uppsala Univeristy Hospital
    Sep 25, 2023

    MDD Trial in United States (Lumateperone, Placebo)

    Recruiting
    • Major Depressive Disorder
    • Pico Rivera, California
    • +17 more
    May 9, 2023

    Schizophrenia Trial in Japan, Korea, Republic of, Taiwan (LY2140023, Placebo)

    Terminated
    • Schizophrenia
    • Aichi, Japan
    • +21 more
    Aug 17, 2021

    Refractory Status Epilepticus Trial in Worldwide (Ganaxolone, Placebo, Standard of care)

    Not yet recruiting
    • Refractory Status Epilepticus
    • Bruxelles, Belgium
    • +11 more
    Apr 3, 2023

    Therapeutic Alliance on Dropout inNaturalistic Sample of

    Completed
    • Borderline Personality Disorder
    • +2 more
    • Dialectical Behavior Therapy
    • Bielefeld, Germany
      Research Department
    Mar 21, 2022

    Medication Adherence Trial in Kaohsiung (the MedAdhere app)

    Enrolling by invitation
    • Medication Adherence
    • the MedAdhere app
    • Kaohsiung, Taiwan
      Kaohsiung Medical University
    Jun 6, 2023

    Status Epilepticus Trial in Albuquerque, Cincinnati, Columbus (IV Ganaxolone, IV Placebo)

    Not yet recruiting
    • Status Epilepticus
    • IV Ganaxolone
    • IV Placebo
    • Albuquerque, New Mexico
    • +2 more
    Mar 8, 2023

    Binge-Eating Disorder Trial in Paris (BP1.4979 active drug, Placebo)

    Recruiting
    • Binge-Eating Disorder
    • BP1.4979 active drug
    • Placebo
    • Paris, France
      Nutrition Department, La Pitié Salpêtrière Hospital
    Mar 7, 2022

    Childhood Trauma in Schizophrenia: Exploration of Links Between

    Recruiting
    • Schizophrenia
    • magnetic resonance imaging (MRI)
    • +2 more
    • Saint-Étienne, France
      CHU de Saint Etienne
    Nov 29, 2022

    MDD Trial in United States (Lumateperone, Placebo)

    Recruiting
    • Major Depressive Disorder
    • Little Rock, Arkansas
    • +16 more
    Apr 7, 2022

    MDD Trial in Worldwide (Lumateperone, Placebo)

    Recruiting
    • Major Depressive Disorder
    • Phoenix, Arizona
    • +27 more
    Apr 7, 2022

    Schizophrenia, Cannabis-Induced Disorder Trial in France (Transcranial direct current stimulation (tDCS) active, Transcranial

    Not yet recruiting
    • Schizophrenia
    • Cannabis-Induced Disorder
    • Transcranial direct current stimulation (tDCS) active
    • Transcranial direct current stimulation (tDCS) non active
    • Bron, France
    • +6 more
    Nov 29, 2022

    Schizophrenia and Related Disorders, Diet Habit Trial in Córdoba (Conventional Dietary Advice, Prebiotic/Probiotic Dietary

    Active, not recruiting
    • Schizophrenia and Related Disorders
    • Diet Habit
    • Conventional Dietary Advice
    • Prebiotic/Probiotic Dietary Modulation
    • Córdoba, Spain
      Universidad de Córdoba.
    Feb 10, 2022

    Relationship Between Major Depression and Periodontal Diseases

    Not yet recruiting
    • Major Depressive Disorder
    • Periodontitis
    • No intervention (observational studies)
    • Madrid, Spain
    • +1 more
    Jul 17, 2023

    Behavior Problems, Neurodevelopmental Disorders Trial in Gothenburg (PR-ESSENCE, Treatment as usual)

    Recruiting
    • Behavior Problems
    • Neurodevelopmental Disorders
    • PR-ESSENCE
    • Treatment as usual
    • Gothenburg, V. Gotaland, Sweden
      Gillberg Neuropsychiatry Centre
    Aug 13, 2022

    Physical Activity, Physical Fitness, and Quality of Life in

    Completed
    • Schizophrenia
    • Diagnose
    • İstanbul, Turkey
      Ebru Akbuğa Koç
    Oct 17, 2022

    Anxiety Disorders Trial in Taipei (Heat-treated PS23, Placebo)

    Not yet recruiting
    • Anxiety Disorders
    • Heat-treated PS23
    • Placebo
    • Taipei, Taiwan
      Mackay Memorial Hospital
    Jul 26, 2023

    Rhinosinusitis Trial in Thái Bình (0.9% NaCl isotonic saline solution, Bacillus subtilis DSM32444, inactivated)

    Completed
    • Rhinosinusitis
    • 0.9% NaCl isotonic saline solution
    • Bacillus subtilis DSM32444, inactivated
    • Thái Bình, Thai Binh, Vietnam
      Thai Binh University of Medicine and Pharmacy
    Aug 8, 2023

    Control of Metabolic and Cardiovascular Risk in Schizophrenia

    Completed
    • Schizophrenia
    • non-interventional
    • (no location specified)
    Feb 18, 2021

    Lactose Intolerance Trial (Active 1, Active 2, Active 3)

    Not yet recruiting
    • Lactose Intolerance
    • Active 1
    • +3 more
    • (no location specified)
    Oct 24, 2023

    Airway Obstruction, Sedation Complication, Safety Issues Trial (Investigational device [I-IV], Comparator [I-IV])

    Not yet recruiting
    • Airway Obstruction
    • +7 more
    • Investigational device [I-IV]
    • Comparator [I-IV]
    • (no location specified)
    Jan 31, 2023

    Alcohol Use Disorder Trial in Aurora (Cannabidiol, Placebo)

    Recruiting
    • Alcohol Use Disorder
    • Aurora, Colorado
      University of Colorado Denver
    Feb 22, 2022

    Post-Traumatic Stress Disorder in Children Trial in Izmir (Testing the the DSM-5 UCLA Posttraumatic Stress Disorder Reaction

    Recruiting
    • Post-Traumatic Stress Disorder in Children
    • Testing the the DSM-5 UCLA Posttraumatic Stress Disorder Reaction Index Self-Report Scale for Children and Adolescents (PTSD-RI-5)
    • İzmir, Turkey
      Dr. Behcet Uz Pediatric Diseases And Surgery Training And Resear
    Oct 5, 2023